Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
13
pubmed:dateCreated
2010-7-27
pubmed:abstractText
5-Aza-2'-deoxycytidine (5-aza-dC) is a nucleoside analogue with cytotoxic and DNA demethylating effects. Here we show that 5-aza-dC induces the proteasomal degradation of free (non-chromatin bound) DNMT1 through a mechanism which is dependent on DNA synthesis and the targeting of incorporated 5-aza-dC residues by DNMT1 itself. Thus, 5-aza-dC induces Dnmt1 degradation in wild-type mouse ES cells, but not in Dnmt [3a(-/-), 3b(-/-)] mouse ES cells which express Dnmt1 but lack DNA methylation (<0.7% of CpG methylated) and contain few hemi-methylated CpG sites, these being the preferred substrates for Dnmt1. We suggest that adducts formed between DNMT1 and 5-aza-dC molecules in DNA induce a ubiquitin-E3 ligase activity which preferentially targets free DNMT1 molecules for degradation by the proteasome. The proteasome inhibitor MG132 prevents DNMT1 degradation and reduces hypomethylation induced by 5-aza-dC.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/20348135-10555141, http://linkedlifedata.com/resource/pubmed/commentcorrection/20348135-11290321, http://linkedlifedata.com/resource/pubmed/commentcorrection/20348135-12397175, http://linkedlifedata.com/resource/pubmed/commentcorrection/20348135-1340468, http://linkedlifedata.com/resource/pubmed/commentcorrection/20348135-15215866, http://linkedlifedata.com/resource/pubmed/commentcorrection/20348135-15456861, http://linkedlifedata.com/resource/pubmed/commentcorrection/20348135-15899874, http://linkedlifedata.com/resource/pubmed/commentcorrection/20348135-16179921, http://linkedlifedata.com/resource/pubmed/commentcorrection/20348135-16963560, http://linkedlifedata.com/resource/pubmed/commentcorrection/20348135-1706062, http://linkedlifedata.com/resource/pubmed/commentcorrection/20348135-17322882, http://linkedlifedata.com/resource/pubmed/commentcorrection/20348135-17991895, http://linkedlifedata.com/resource/pubmed/commentcorrection/20348135-19129216, http://linkedlifedata.com/resource/pubmed/commentcorrection/20348135-19417133, http://linkedlifedata.com/resource/pubmed/commentcorrection/20348135-19502488, http://linkedlifedata.com/resource/pubmed/commentcorrection/20348135-3558369, http://linkedlifedata.com/resource/pubmed/commentcorrection/20348135-5696931, http://linkedlifedata.com/resource/pubmed/commentcorrection/20348135-6156004, http://linkedlifedata.com/resource/pubmed/commentcorrection/20348135-6187927, http://linkedlifedata.com/resource/pubmed/commentcorrection/20348135-8898232, http://linkedlifedata.com/resource/pubmed/commentcorrection/20348135-9302295
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1362-4962
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
38
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
4313-24
pubmed:dateRevised
2010-9-30
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
Targeting of 5-aza-2'-deoxycytidine residues by chromatin-associated DNMT1 induces proteasomal degradation of the free enzyme.
pubmed:affiliation
Breakthrough Research Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't